# CG ONCOLOGY INC (CGON)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CGON/

- Reporting holders: 5
- Reported value: $83.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $76.6K | 1,081 | 0.0% | 9 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $2.8K | 39 | 0.0% | 8 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.7K | 38 | 0.0% | 5 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $1.4K | 20 | 0.0% | 1 |
| [Planning Strategies Inc.](https://holderbook.com/funds/2139665-planning-strategies-inc/) | $71 | 1 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $83.6K |
| Q2 2026 | 240 | $7.3B |
| Q1 2026 | 238 | $6.3B |
| Q4 2025 | 199 | $3.6B |
| Q3 2025 | 181 | $3.2B |
| Q2 2025 | 165 | $2.0B |
| Q1 2025 | 143 | $1.7B |
| Q4 2024 | 141 | $1.9B |
| Q3 2024 | 121 | $2.0B |
| Q2 2024 | 110 | $1.4B |
| Q1 2024 | 97 | $1.7B |